IN8BIO, INC. Public Float
IN8BIO, INC. (INAB) had Public Float of $7.60 million as of 2025-06-30, per its 10-K filed 2026-03-12.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-12
- 2025-06-30: Entity Public Float $7.60M.
- 2024-06-28: Entity Public Float $29.00M.
- 2023-06-30: Entity Public Float $22.70M.
- 2022-06-30: Entity Public Float $5.90M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $7.60M 10-K · filed 2026-03-12 |
| 2024-06-28 | $29.00M 10-K/A · filed 2025-05-07 |
| 2023-06-30 | $22.70M 10-K · filed 2024-03-14 |
| 2022-06-30 | $5.90M 10-K · filed 2023-03-30 |
| 2021-07-30 | $61.50M 10-K · filed 2022-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B |